$NVLX owns exclusive rights to a cancer treatment
Post# of 63696
Posted On: 02/26/2014 8:39:18 AM
$NVLX owns exclusive rights to a cancer treatment platform that has successfully completed Phase 2 clinical trials for inoperable pancreatic cancer. Nuvilex also owns rights to the same platform to treat diabetes, and the company also has a medical marijuana subsidiary slated to begin cancer research and development using cannabidiol. With each of the key target markets representing multi-billion-dollar opportunities, Nuvilex offers investors multiple opportunities for success and should trade at a valuation that reflects its current development progress to date.
(0)
(0)Scroll down for more posts ▼